IPP Bureau
Barentz to showcase clinically proven nutraceutical solutions at Vitafoods Europe 2026
By IPP Bureau - April 30, 2026
Company to highlight science-backed actives, nature-powered ingredients, and its new “Natural by Barentz” private label platform in Barcelona
Sun Pharma Advanced Research Company to sell priority review voucher for $195 Million
By IPP Bureau - April 30, 2026
SPARC enters definitive agreement to monetise rare paediatric disease PRV, unlocking capital for R&D and strategic growth
Apollo TeleHealth expands integrated healthcare services to Sri City in Tamil Nadu
By IPP Bureau - April 30, 2026
New medical and wellness centre combines on-site care with telehealth to support industrial workforce and surrounding communities
JP Nadda highlights India’s expanding healthcare ecosystem at PGIMER convocation
By IPP Bureau - April 30, 2026
Union health minister urges graduates in Chandigarh to combine technological excellence with compassion in medical practice
India–New Zealand FTA elevates AYUSH systems to global stage with dedicated traditional medicine framework
By IPP Bureau - April 30, 2026
Landmark agreement opens market access, mobility pathways, and institutional collaboration for Ayurveda, Yoga, and holistic healthcare services
Parexel acquires Vitrana to strengthen AI-driven patient safety capabilities
By IPP Bureau - April 30, 2026
Acquisition enhances integrated pharmacovigilance platform, combining AI, automation, and services to improve compliance, efficiency, and end-to-end clinical safety operations
Cardioline acquires Cardios to expand global telecardiology footprint
By IPP Bureau - April 30, 2026
Backed by ARCHIMED, the deal strengthens connected cardiac diagnostics with integrated Holter, ABPM, and telemedicine solutions
Kahimmune Therapeutics signs agreement for scientific collaboration with Gustave Roussy
By IPP Bureau - April 29, 2026
Collaboration to accelerate mRNA neoantigen therapy development for colorectal and pancreatic cancers using advanced immunology and dark genome insights
Leinco Technologies and CellCarta partner to advance proteomics in immuno-oncology
By IPP Bureau - April 29, 2026
The combined offering is designed to support a wide range of applications, from pilot-scale research to high-volume clinical use
Sanofi Consumer Healthcare reports 33% revenue growth in Q1 FY26; PAT rises 36%
By IPP Bureau - April 29, 2026
Domestic sales increased 15.5%, supported by the relaunch of previously recalled products in the market
Gleneagles BGS Hospital launches HEAL Health Card to expand access to affordable care
By IPP Bureau - April 29, 2026
The initiative is designed to benefit patients as well as healthcare providers by streamlining access to consultations, diagnostics, and essential care services
Pfizer locks in long runway for blockbuster heart drug after key patent settlements
By IPP Bureau - April 29, 2026
The deals, tied to cases in the US District Court for the District of Delaware, effectively extend US patent protection for VYNDAMAX until June 1, 2031
Evonik and Higuchi launch “Open Pharma Lab” in Yokohama to accelerate oral drug Innovation
By IPP Bureau - April 29, 2026
EUDRAGIT polymers remain a cornerstone technology in oral drug delivery
OneSource Pharma, Dr Reddy’s secure Health Canada nod for generic Semaglutide
By IPP Bureau - April 29, 2026
Approval for generic Semaglutide Injection strengthens CDMO partnership, enabling scalable supply from OneSource’s US FDA-approved Bengaluru facility
